You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 074502

✉ Email this page to a colleague

« Back to Dashboard

NDA 074502 describes ISOFLURANE, which is a drug marketed by Halocarbon Prods, Hospira, Piramal Critical, Piramal Pharma, Shandong, and Watson Labs Inc, and is included in six NDAs. It is available from four suppliers. Additional details are available on the ISOFLURANE profile page.

The generic ingredient in ISOFLURANE is isoflurane. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the isoflurane profile page.

Summary for 074502

Tradename:	ISOFLURANE
Applicant:	Piramal Pharma
Ingredient:	isoflurane
Patents:	0

Pharmacology for NDA: 074502

Physiological Effect	General Anesthesia

Medical Subject Heading (MeSH) Categories for 074502

Anesthetics, Inhalation

Suppliers and Packaging for NDA: 074502

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ISOFLURANE	isoflurane	LIQUID;INHALATION	074502	ANDA	Piramal Critical Care, Inc.	66794-017	66794-017-10	100 mL in 1 BOTTLE, GLASS (66794-017-10)
ISOFLURANE	isoflurane	LIQUID;INHALATION	074502	ANDA	Piramal Critical Care, Inc.	66794-017	66794-017-25	250 mL in 1 BOTTLE, GLASS (66794-017-25)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	LIQUID;INHALATION			Strength	99.9%
Approval Date:	Jun 27, 1995	TE:	AN	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.